NEW ENGL J MED 润色咨询

NEW ENGLAND JOURNAL OF MEDICINE

出版年份:暂无数据 年文章数:2882 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:0.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2024-03-04 维新Tuo1887878 来自广西

    qudao tougao15994441457

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2021-02-07 12103978m50暂无昵称

    投了一篇letter不知道with edtor要多少天

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2024-01-23 ms6000000966266302 来自重庆

    23.12.17投稿 picture,with the editor 一月有余

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2023-11-09 ms2000001241893328 来自山东省

    偏重的研究方向:临床研究
    经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2016-02-27 zhihenghuang

    投了1篇病例报道,现在Assigned to an Editor,估计希望不大。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2023-07-14 ms6000000447690824 来自广东省

    审稿速度:3.0 | 投稿命中率:5.0
    偏重的研究方向:随机对照研究
    经验分享:规范的多中心大样本的文章临床文章相对容易点被接收

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2022-04-27 大學朝陽

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:神经病学;神经介入
    经验分享:Images in Clinical Medicine收录

    18

    展开18条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2023-06-29 侠胆医心 来自香港

    审稿速度:3.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤;综合医学;心血管
    经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2023-02-02 12588598m48暂无昵称 来自福建省

    偏重的研究方向:genetics;neurology
    经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急)

    11

    展开11条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2190983, encodeId=5d642190983ac, content=qudao tougao15994441457, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 16:47:21 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture,with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向:临床研究<br>经验分享:2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道,现在Assigned to an Editor,估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=883, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:随机对照研究<br>经验分享:规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:神经病学;神经介入<br>经验分享:Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1869, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;综合医学;心血管<br>经验分享:影响因子158.5分,虽然比Lancet的168.9略低,但是原因在于NEJM上发表的新冠文章少,引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向:genetics;neurology<br>经验分享:针对NEJM最近发的article写了一个letter过去,已经一个半月了还是letter submitted状态,没有变成with the editor不知道是什么情况,有哪位仁兄碰到过这种情况的吗T T (着急), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:寄生虫病<br>经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1706, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=)]
    2022-06-29 刘小川

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:寄生虫病
    经验分享:2022年2月12日投稿,4月16日要求修改,5月5日返回,5月19日再次修改(仅询问是否能添加一句话),5月23日返回,至今一直是with the editor,也不知道什么情况

    5

    展开5条回复
共212条页码: 1/22页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分